|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Herbst RS, Heymach JV and Lippman SM: Lung
cancer. N Engl J Med. 359:1367–1380. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Imielinski M, Berger AH, Hammerman PS,
Hernandez B, Pugh TJ, Hodis E, Cho J, Suh J, Capelletti M,
Sivachenko A, et al: Mapping the hallmarks of lung adenocarcinoma
with massively parallel sequencing. Cell. 150:1107–1120. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Smith BN and Bhowmick NA: Role of EMT in
metastasis and therapy resistance. J Clin Med. 5:pii: E17. 2016.
View Article : Google Scholar
|
|
5
|
Lamouille S, Xu J and Derynck R: Molecular
mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell
Biol. 15:178–196. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Seton-Rogers S: Epithelial-mesenchymal
transition: Untangling EMT's functions. Nat Rev Cancer. 16:12016.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang DX, Zou YJ, Zhuang XB, Chen SX, Lin
Y, Li WL, Lin JJ and Lin ZQ: Sulforaphane suppresses EMT and
metastasis in human lung cancer through miR-616-5p-mediated
GSK3β/β-catenin signaling pathways. Acta Pharmacol Sin. 38:241–251.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ye Z, Yin S, Su Z, Bai M, Zhang H, Hei Z
and Cai S: Downregulation of miR-101 contributes to
epithelial-mesenchymal transition in cisplatin resistance of NSCLC
cells by targeting ROCK2. Oncotarget. 7:37524–37535. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen S, Jiao S, Jia Y and Li Y: Effects of
targeted silencing of FOXC1 gene on proliferation and in vitro
migration of human non-small-cell lung carcinoma cells. Am J Transl
Res. 8:3309–3318. 2016.PubMed/NCBI
|
|
10
|
Rakvin B, Zilić D, North JM and Dalal NS:
Probing magnetic fields on crystals of the nanomagnet Mn12-acetate
by electron paramagnetic resonance. J Magn Reson. 165:260–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Morello A, Bakharev ON, Brom HB, Sessoli R
and de Jongh LJ: Nuclear spin dynamics in the quantum regime of a
single-molecule magnet. Phys Rev Lett. 93:1972022004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Guo C, Zhao D, Zhang Q, Liu S and Sun MZ:
miR-429 suppresses tumor migration and invasion by targeting CRKL
in hepatocellular carcinoma via inhibiting Raf/MEK/ERK pathway and
epithelial-mesenchymal transition. Sci Rep. 8:23752018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Amoroso MR, Matassa DS, Agliarulo I,
Avolio R, Lu H, Sisinni L, Lettini G, Gabra H, Landriscina M and
Esposito F: TRAP1 downregulation in human ovarian cancer enhances
invasion and epithelial-mesenchymal transition. Cell Death Dis.
7:e25222016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liang W, Lai Y, Zhu M, Huang S, Feng W and
Gu X: Combretastatin A4 regulates proliferation, migration,
invasion, and apoptosis of thyroid cancer cells via PI3K/Akt
signaling pathway. Med Sci Monit. 22:4911–4917. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hammers H, Fu C, Gerber S, Berg SVD,
Steenwinkel F, Moriarty W, Keizman D, Kachhap S and Carducci MA:
Epithelial-mesenchymal transition: A mechanism of resistance to
VEGF pathway inhibition in genitourinary cancers. J Clin Oncol. 30
5_suppl:S3902012. View Article : Google Scholar
|
|
17
|
Liu MH, Fu WJ, Cui YH, Guo QN and Zhou Y:
Downregulation of Semaphorin-3F is associated with poor prognostic
significance in osteosarcoma patients. Am J Cancer Res.
6:2252–2262. 2016.PubMed/NCBI
|
|
18
|
Liu B, Pan CF, He ZC, Wang J, Wang PL, Ma
T, Xia Y and Chen YJ: Long noncoding RNA-LET suppresses tumor
growth and EMT in lung adenocarcinoma. Biomed Res Int.
2016:46934712016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhu FQ, Chen MJ, Zhu M, Zhao RS, Qiu W, Xu
X, Liu H, Zhao HW, Yu RJ, Wu XF, et al: Curcumin suppresses
epithelial-mesenchymal transition of renal tubular epithelial cells
through the inhibition of Akt/mTOR pathway. Biol Pharm Bull.
40:17–24. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim S, Koh J, Kim MY, Kwon D, Go H, Kim
YA, Jeon YK and Chung DH: PD-L1 expression is associated with
epithelial-to-mesenchymal transition in adenocarcinoma of the lung.
Hum Pathol. 58:7–14. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Larsen JE and Minna JD: Molecular biology
of lung cancer: Clinical implications. Clin Chest Med. 32:703–740.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Arai K, Eguchi T, Rahman MM, Sakamoto R,
Masuda N, Nakatsura T, Calderwood SK, Kozaki K and Itoh M: A novel
high-throughput 3D screening system for EMT inhibitors: A pilot
screening discovered the EMT inhibitory activity of CDK2 inhibitor
SU9516. PLoS One. 11:e01623942016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dopeso H, Jiao HK, Cuesta AM, Henze AT,
Jurida L, Kracht M, Acker-Palmer A, Garvalov BK and Acker T: PHD3
controls lung cancer metastasis and resistance to EGFR inhibitors
through TGFα. Cancer Res. 78:1805–1819. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shao L, Li H, Chen J, Song H, Zhang Y, Wu
F, Wang W, Zhang W, Wang F, Li H and Tang D: Irisin suppresses the
migration, proliferation, and invasion of lung cancer cells via
inhibition of epithelial-to-mesenchymal transition. Biochem Biophys
Res Commun. 485:598–605. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao Z, Liu H, Hou J, Li T, Du X, Zhao X,
Xu W, Xu W and Chang J: Tumor protein D52 (TPD52) inhibits growth
and metastasis in renal cell carcinoma cells through the PI3K/Akt
signaling pathway. Oncol Res. 25:773–779. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang Y, Bai YS and Wang Q: CDGSH iron
sulfur domain 2 activates proliferation and EMT of pancreatic
cancer cells via Wnt/β-catenin pathway and has prognostic value in
human pancreatic cancer. Oncol Res. 25:605–615. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang E, Wang D, Li B, Ma H, Wang C, Guan
L, Zhang H, Yi L and Li S: Capn4 promotes epithelial-mesenchymal
transition in human melanoma cells through activation of the
Wnt/β-catenin pathway. Oncol Rep. 37:379–387. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zuo Q, Huang S, Zou Y, Xu Y, Jiang Z, Zou
S, Xu H and Sun L: The Lnc RNA SPRY4-IT1 modulates trophoblast cell
invasion and migration by affecting the epithelial-mesenchymal
transition. Sci Rep. 6:371832016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chatterjee J, Dai W, Aziz NHA, Teo PY,
Wahba J, Phelps DL, Maine CJ, Whilding LM, Dina R, Trevisan G, et
al: Clinical use of programmed cell death-1 and its ligand
expression as discriminatory and predictive markers in ovarian
cancer. Clin Cancer Res. 23:3453–3460. 2017. View Article : Google Scholar : PubMed/NCBI
|
